Press release
Grand Mal Seizure Treatment Market Size, Share, Trends And Forecast 2024 To 2033
Grand Mal Seizure Treatment Market Size
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12349&type=smp
According to The Business Research Company's, The grand mal seizure treatment market size has grown strongly in recent years. It will grow from $1.91 billion in 2023 to $2.02 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to neurological understanding, medical advancement, medication development, development of seizure classification, legal and social advocacy.
The grand mal seizure treatment market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to genetic research and precision medicine, telemedicine for remote care, regulatory changes in accessibility, enhanced brain imaging techniques, holistic approach in treatment. Major trends in the forecast period include global advocacy for epilepsy awarenes, patient-centered care models, expanded research in seizure genetics, community support networks, non-pharmacological treatment approaches.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/grand-mal-seizure-treatment-global-market-report
Market Drivers and Trends:
The high prevalence of epilepsy is expected to propel the growth of the grand mal seizure treatment market going forward. Epilepsy is a neurological disorder in which the patient suffers from recurring seizures. Grand mal seizures are often caused by epilepsy and produce violent seizures. Increasing prevalence increases the need for better treatment, which can be achieved using grand mal seizure treatment. For instance, in February 2023, according to the World Health Organization, a Switzerland-based public health agency of the United Nations, approximately 50 million people in the world were suffering from epilepsy, making it one of the most prevalent neurological conditions worldwide. Every year, about 5 million people are diagnosed with epilepsy. Therefore, the high prevalence of epilepsy is driving the growth of the grand mal seizure treatment market.
Major companies operating in the grand mal seizure treatment market are developing new products such as anti-epilepsy medications to gain a competitive edge in the market. Anti-epilepsy medications, also known as antiepileptic drugs (AEDs) or anticonvulsants, are a class of pharmaceuticals designed to manage and treat epileptic seizures and related disorders. For instance, in January 2023, Zydus Lifesciences Limited, an India-based pharmaceutical company, launched the Topiramate extended-release capsules in the U.S. market. The generic anti-epilepsy medication is available in strengths of USP 25 mg, 50 mg, and 100 mg, making Zydus the first company to receive final approval and introduce the product in these strengths. The capsules are indicated for epilepsy treatment, specifically as initial monotherapy for patients aged six and older with partial-onset or primary generalized tonic-clonic seizures, as well as for migraine prophylaxis in patients aged 12 and older.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., Johnson & Johnson Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceuticals Inc., Mylan N.V., UCB Celltech Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Cipla Inc., Apotex Inc., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Strides Pharma Science Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Macleods Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Indoco Remedies Limited, Spectrum Chemical Mfg. Corp.
Grand Mal Seizure Treatment Market 2024 Key Insights:
• The grand mal seizure treatment market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%.
• Rising Prevalence Of Epilepsy To Drive Market Growth
• Product Innovations Transforming The Grand Mal Seizure Treatment Market
• North America was the largest region in the grand mal seizure treatment market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12349&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Grand Mal Seizure Treatment Market Size, Share, Trends And Forecast 2024 To 2033 here
News-ID: 3777122 • Views: …
More Releases from The Business research company
Ophthalmology Medical Service Market Study Highlights How Industry Demand Is Evo …
The ophthalmology medical service sector is on track for significant expansion as advancements in technology and treatment options reshape eye care. With increasing demand for innovative procedures and diagnostic tools, the market is positioned for robust growth over the coming years. Here is an overview of the market size, key players, emerging trends, and segmentation that define this evolving industry.
Projected Size and Growth Outlook for the Ophthalmology Medical Service Market…
Operating Tables Market Research Reveals Strong 5.1% CAGR Outlook Through 2030
The operating tables market is poised for notable expansion in the coming years, driven by technological innovations and rising healthcare demands. As surgical procedures become more specialized and integrated with advanced systems, the demand for versatile and efficient operating tables is increasing steadily. Let's explore the current market size, key players, trends, and segmented insights shaping this dynamic sector.
Expected Market Growth for Operating Tables by 2030
Forecasts indicate that…
Open-Angle Glaucoma (OAG) Market Intelligence Report Covers Trends, Segments And …
The open-angle glaucoma market is on track for significant expansion as advances in treatment and technology reshape patient care. Driven by increasing access to digital therapies and innovative surgical options, this sector is attracting considerable attention from healthcare providers and patients alike. Let's explore the current market size, key players, emerging trends, and detailed segmentation shaping the future of open-angle glaucoma management.
Projected Market Growth and Size of the Open-Angle Glaucoma…
Online/Virtual Fitness Market Trends Support A 28% CAGR Outlook Through The Fore …
The online and virtual fitness industry is on the verge of remarkable expansion as technology and personalized experiences redefine how people engage with exercise. With consumers increasingly seeking convenient, interactive, and tailored fitness solutions, this market is set to transform the landscape of health and wellness in the coming years. Let's explore the market's projected growth, key players, influential trends, and segment dynamics shaping its future.
Projected Growth and Market Size…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
